Collagen manufactured from transgenic tobacco plants

A scientist at the Hebrew University of Jerusalem's Robert H. Smith Faculty of Agriculture, Food and Environment has succeeded in producing a replica of human collagen from tobacco plants - an achievement with tremendous commercial implications for use in a variety of human medical procedures.

Natural human type I collagen is the most abundant protein in the human body and is the main protein found in all connective tissue. Commercially produced collagen (pro-collagen) is used in surgical implants and many wound healing devices in regenerative medicine. The current market for collagen-based medical devices in orthopedics and exceeds US $30 billion annually worldwide.

Currently, commercial is produced from farm animals such as cows and pigs as well as from human cadavers. These materials are prone to harbor human pathogens such as viruses or prions (mad-cow disease). Human cadaver is scarce, and for certain indications possesses serious ethical issues.

Producing human recombinant type I pro-collagen requires the coordinated expression of five different genes. Prof. Oded Shoseyov of the Robert H. Smith Institute of Plant Sciences and Genetics in Agriculture has established the only laboratory in the world that has reported successful co-expression all the five essential genes in transgenic for the production of processed pro-collagen. For this work, Shoseyov was one of the recipients of a Kaye Innovation Award during the Hebrew University Board of Governors meeting in June.

Shoseyov's invention on has been patented, and the scientific findings behind it were published recently in the journal Biomacromolecules. A company, CollPlant Ltd., has been established based on patents and technology that were developed in Shoseyov's laboratory. It has raised US$15 million to establish the first commercial molecular farming company in Israel and is already manufacturing collagen-based products that have attracted collaborative commercial interest from companies in the US, Japan Europe and Israel.

Yissum, the technology transfer company of the Hebrew University, is one of the shareholders of CollPlant.. CollPlant is a public company traded in "TASE", and the potential revenue for the Hebrew University from this invention is estimated to reach into the multi-million dollar range.

The Kaye Awards have been given annually since 1994. Isaac Kaye of England, a prominent industrialist in the pharmaceutical industry, established the awards to encourage faculty, staff, and students of the Hebrew University to develop innovative methods and inventions with good commercial potential which will benefit the university and society.

Explore further

Research leads to advanced trials of new cancer treatment

Citation: Collagen manufactured from transgenic tobacco plants (2010, June 10) retrieved 21 July 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Jun 10, 2010
Where is this technology taking us?

This is just dreadful ethically, because we are starting to take human dna and put it into things for the purpose of harvesting protiens (and no doubt eventually organs) just like the "bad guys" in classic science fiction and horror.

The thought of someone potentially SMOKING a cigarette made from tobacco plant that has human DNA is just terrible.

It seems like a modern, "politically correct" form of cannibalism.

What next? Will we engineer clones of ourselves and harvest organs like in Gattica?

Will we engineer a genetic "caste" system with semi-sentient slave race, as in the Morlocks of the "Time Machine" book and movie?

Animal-like plants and plant-like animals?

When will this abomination stop, and what will be left of "real" nature?

Jul 04, 2010
I don't think they plan to sell the tobacco for cigarettes after they do this. Instead, they are looking for ways to make tobacco plant (farms) remain useful as the plant's prime market continues to erode.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more